NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Joel Danziger received the devastating diagnosis of glioblastoma in the summer of 2019.
Within a few days he was having emergency brain surgery to remove a golf ball sized brain tumour.
On the 25th March 2021 Joel had his very first dose of Dendritic Cell Vaccine, (DCVax-L). The treatment, at Kings College Hospital in London, was administered by Keyoumars Ashkan, Professor of Neurosurgery and his team. Joel was then his one and only patient having this treatment. (due to Covid precautions.)
On the 5th of May 2021 Joel had his fourth and final dose of DCVax-L (Not enough tumour tissue to made more than 4 vaccine doses)

UPDATE
June 24, 2023

Ian Runacres

"Whenever Joel comes home we go to his fave Chinese restaurant. Drinking Lucky Buddha beer and he was as Joels’s scan results are stable. Huge relief."

https://www.facebook.com/photo/?fbid=5990804394380329&set=a.323065227820969